Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
